Exosystems to conduct trial run of new ICT rehabilitation solution in Vietnam

Food and Healthcare Press Releases Thursday October 11, 2018 08:25
SEOUL, South Korea--11 Oct--PRNewswire/InfoQuest
The healthcare robotics company Exosystems will soon be conducting a trial run of its ICT muscular rehabilitation solution "ExoRehab" at hospitals in Vietnam.

Exosystems, a member company of the K-ICT Born2Global Centre, has signed a partnership contract with Medipeace Vietnam, which is already involved in local rehabilitative care projects, and plans to introduce ExoRehab in Vietnamese hospitals by December 2018. Medipeace is an NGO that conducts medical support projects around the world.

Developed independently by Exosystems, ExoRehab is a next-generation muscular rehabilitation solution that combines medical treatment with information and communications technology. Used in conjunction with neuromuscular electrical stimulation (NMES), the treatment method currently in use, it has patients play rehabilitative games developed by medical professionals and provides a systematic rehabilitative care program. ExoRehab effectively accelerates patients' rehabilitation rates and assists medical personnel in the provision of effective patient care and management.

Through its partnership with Medipeace Vietnam, Exosystems will be entering both the Korean and international rehabilitation markets. The conformance test for ExoRehab was completed at Wonju Severance Christian Hospital in November 2017, and clinical testing with Seoul National University Bundang Hospital is currently underway. The product is scheduled to be released in the North American market in the second half of 2019.

Exosystems founder and CEO Hooman Lee said, "Exosystems completed the development and certification procedures for our ExoRehab device within just a year and a half after the company's founding in January 2017, and is working quickly to supply the product to our clients. We hope that the trial run of ExoRehab in Vietnam will promote the provision of advanced technology in the field of rehabilitative care, which is a major aspect of the problem of population aging that many countries around the world are now facing."

Exosystems was founded by researchers specialized in intelligent robotic systems who were formerly affiliated with the Electronics and Telecommunications Research Institute. In May 2017, the company received an investment of KRW 300 million from Kakao Ventures, a renowned Korean venture capital firm.

For more detailed information on Exosystems, visit https://www.exosystems.io/.
Media Contact
Hooman Lee
CEO of Exosystems
exosystems@exosystems.io
Jina Lee
PR Manager of Born2Global
jlee@born2global.com
Photo - https://photos.prnasia.com/prnh/20181005/2258781-1-a
Photo - https://photos.prnasia.com/prnh/20181008/2258781-1-b

Latest Press Release

Merck Announces FDA Orphan Drug Designation for Bifunctional Immunotherapy M7824 in Biliary Tract Cancer

- FDA grants M7824, an investigational bifunctional immunotherapy, orphan drug designation in biliary tract cancer - First regulatory designation for M7824 following recent presentation of first clinical data in BTC - BTC is a group of rare, aggressive...

Merck in Agreement With Cyclica for AI-augmented Screening Platform to Expand Research Capabilities

- Agreement to screen discovery and early development compounds using artificial intelligence and computational biophysics - Cloud-based in silico platform that screens small molecules to determine polypharmacological profiles - Evaluation to include...

Vitality-linked Insurers to Get 100 million People 20% More Active by 2025

Building on the results of the largest behaviour change study on physical activity, Vitality and its global network of insurers have collectively committed to improving the health of millions over the next seven years. This is in line with the World...

World Congress of Cardiology Cardiovascular Health 2018 Opens in Dubai

- Professor David Wood, President of the World Heart Federation, welcomes more than 5000 cardiologists, doctors, nurses, and health and policy experts from around the world to Dubai for WCC 2018 at a time when the opportunities for a sustainable impact...

Data Presented at 2nd Healthy Lung Summit 2018 to Demonstrate Impact of AstraZeneca#s Healthy Lung Partnership Programme

Deepening commitment to drive improvements for patients with respiratory disease across Asia, AstraZeneca with Business Sweden, The Swedish Trade & Invest Council in Taiwan, hosts the second Healthy Lung Summit, ahead of the 2018 Asia Pacific Society...

Related Topics